Global PD-L1 Biomarker Testing Market Growth (Status and Outlook) 2020-2025
- ID:PD051944
- August 2020
- LPI (LP Information)
Single User License: $3,660.00
Multi User License: $5,490.00
Enterprise License: $7,320.00
The global PD-L1 Biomarker Testing market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform. The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels. For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.
According to this study, over the next five years the PD-L1 Biomarker Testing market will register a 45.7% CAGR in terms of revenue, the global market size will reach $ 3000.1 million by 2025, from $ 665.8 million in 2019. In particular, this report presents the global revenue market share of key companies in PD-L1 Biomarker Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-L1 Biomarker Testing market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the PD-L1 Biomarker Testing, covering the supply chain analysis, impact assessment to the PD-L1 Biomarker Testing market size growth rate in several scenarios, and the measures to be undertaken by PD-L1 Biomarker Testing companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
According to this study, over the next five years the PD-L1 Biomarker Testing market will register a 45.7% CAGR in terms of revenue, the global market size will reach $ 3000.1 million by 2025, from $ 665.8 million in 2019. In particular, this report presents the global revenue market share of key companies in PD-L1 Biomarker Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-L1 Biomarker Testing market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the PD-L1 Biomarker Testing, covering the supply chain analysis, impact assessment to the PD-L1 Biomarker Testing market size growth rate in several scenarios, and the measures to be undertaken by PD-L1 Biomarker Testing companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
- PD-L1 (22C3)
- PD-L1(28-8)
- PD-L1 (SP142)
- PD-L1 (SP263)
- Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
- Hospital
- Diagnostic Center
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- Agilent Technologies
- Junshi Biosciences
- Roche
- Bristol-Myers Squibb
- AstraZeneca
- Merck
- Innovent
- Ono Pharmaceutical
- Hengrui Medicine
- Regeneron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global PD-L1 Biomarker Testing market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of PD-L1 Biomarker Testing market by identifying its various subsegments.
- Focuses on the key global PD-L1 Biomarker Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the PD-L1 Biomarker Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of PD-L1 Biomarker Testing submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size 2015-2025
2.1.2 PD-L1 Biomarker Testing Market Size CAGR by Region
2.2 PD-L1 Biomarker Testing Segment by Type
2.2.1 PD-L1 (22C3)
2.2.2 PD-L1 (22C3)
2.2.3 PD-L1 (SP142)
2.2.4 PD-L1 (SP263)
2.2.5 Other
2.3 PD-L1 Biomarker Testing Market Size by Type
2.3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
2.3.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (2015-2020)
2.4 PD-L1 Biomarker Testing Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 PD-L1 Biomarker Testing Market Size by Application
2.5.1 Global PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
2.5.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (2015-2020)
3 Global PD-L1 Biomarker Testing by Players
3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Players
3.1.1 Global PD-L1 Biomarker Testing Market Size by Players (2018-2020)
3.1.2 Global PD-L1 Biomarker Testing Market Size Market Share by Players (2018-2020)
3.2 Global PD-L1 Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PD-L1 Biomarker Testing by Regions
4.1 PD-L1 Biomarker Testing Market Size by Regions
4.2 Americas PD-L1 Biomarker Testing Market Size Growth
4.3 APAC PD-L1 Biomarker Testing Market Size Growth
4.4 Europe PD-L1 Biomarker Testing Market Size Growth
4.5 Middle East & Africa PD-L1 Biomarker Testing Market Size Growth
5 Americas
5.1 Americas PD-L1 Biomarker Testing Market Size by Countries
5.2 Americas PD-L1 Biomarker Testing Market Size by Type
5.3 Americas PD-L1 Biomarker Testing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC PD-L1 Biomarker Testing Market Size by Regions
6.2 APAC PD-L1 Biomarker Testing Market Size by Type
6.3 APAC PD-L1 Biomarker Testing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe PD-L1 Biomarker Testing by Countries
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa PD-L1 Biomarker Testing by Countries
8.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by ...
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size 2015-2025
2.1.2 PD-L1 Biomarker Testing Market Size CAGR by Region
2.2 PD-L1 Biomarker Testing Segment by Type
2.2.1 PD-L1 (22C3)
2.2.2 PD-L1 (22C3)
2.2.3 PD-L1 (SP142)
2.2.4 PD-L1 (SP263)
2.2.5 Other
2.3 PD-L1 Biomarker Testing Market Size by Type
2.3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
2.3.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (2015-2020)
2.4 PD-L1 Biomarker Testing Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 PD-L1 Biomarker Testing Market Size by Application
2.5.1 Global PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
2.5.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (2015-2020)
3 Global PD-L1 Biomarker Testing by Players
3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Players
3.1.1 Global PD-L1 Biomarker Testing Market Size by Players (2018-2020)
3.1.2 Global PD-L1 Biomarker Testing Market Size Market Share by Players (2018-2020)
3.2 Global PD-L1 Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PD-L1 Biomarker Testing by Regions
4.1 PD-L1 Biomarker Testing Market Size by Regions
4.2 Americas PD-L1 Biomarker Testing Market Size Growth
4.3 APAC PD-L1 Biomarker Testing Market Size Growth
4.4 Europe PD-L1 Biomarker Testing Market Size Growth
4.5 Middle East & Africa PD-L1 Biomarker Testing Market Size Growth
5 Americas
5.1 Americas PD-L1 Biomarker Testing Market Size by Countries
5.2 Americas PD-L1 Biomarker Testing Market Size by Type
5.3 Americas PD-L1 Biomarker Testing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC PD-L1 Biomarker Testing Market Size by Regions
6.2 APAC PD-L1 Biomarker Testing Market Size by Type
6.3 APAC PD-L1 Biomarker Testing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe PD-L1 Biomarker Testing by Countries
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa PD-L1 Biomarker Testing by Countries
8.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by ...
Related Categories :
Medical Devices
www.decisiondatabases.com is a online aggregator of market and research database which includes databases, reports and profiles. We have started this portal with a aim to become one stop shop provider for marketing and research data requirements for various sector and country databases.
Main Categories
